Promisia Healthcare Ltd
NZX:PHL

Watchlist Manager
Promisia Healthcare Ltd Logo
Promisia Healthcare Ltd
NZX:PHL
Watchlist
Price: 0.48 NZD -2.04% Market Closed
Market Cap: 25.3m NZD
Section:
 

Relative Value

PHL doesn't have a meaningful market cap.

The Relative Value of one PHL stock under the Base Case scenario is 1.13 NZD. Compared to the current market price of 0.48 NZD, Promisia Healthcare Ltd is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHL Relative Value
Base Case
1.13 NZD
Undervaluation 57%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
82
vs Industry
61
Median 3Y
0.9
Median 5Y
456.7
Industry
1.1
More Details
25.2
P/E
P/E
Price to Earnings
25.2
vs History
50
vs Industry
61
Median 3Y
25.2
Median 5Y
25.2
Industry
17.8
More Details
19
P/OCF
P/OCF
Price to OCF
19
vs History
50
vs Industry
61
Median 3Y
3
Median 5Y
19
Industry
11.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
53
Median 3Y
2.9
Median 5Y
1.8
Industry
15.7
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
69
vs Industry
74
Median 3Y
0.9
Median 5Y
1.1
Industry
1.6
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
96
vs Industry
22
Median 3Y
2.3
Median 5Y
458
Industry
1.2
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4
More Details
24.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24.5
vs History
69
vs Industry
39
Median 3Y
26.2
Median 5Y
27
Industry
10.5
More Details
24.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.5
vs History
69
vs Industry
46
Median 3Y
26.2
Median 5Y
27
Industry
13.7
More Details
53.9
EV/OCF
EV/OCF
Enterprise Value to OCF
53.9
vs History
50
vs Industry
44
Median 3Y
7.1
Median 5Y
53.9
Industry
12.5
More Details
56.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
56.8
vs History
12
vs Industry
40
Median 3Y
-101.2
Median 5Y
-111.2
Industry
15.6
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
71
vs Industry
77
Median 3Y
0.6
Median 5Y
0.7
Industry
1.2
More Details

Multiples Across Competitors

PHL Competitors Multiples
Promisia Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Promisia Healthcare Ltd
NZX:PHL
25.2m NZD 0.7 25.2 24.5 24.5
FR
L'Oreal SA
PAR:OR
197.7B EUR 4.5 32.3 18.7 22.8
UK
Unilever PLC
LSE:ULVR
119.9B GBP 2.3 23.8 202.2 234.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 8.3 49.2 35.7 39.5
UK
HALEON PLC
LSE:HLN
33.4B GBP 3 23.3 14 15.9
US
Estee Lauder Companies Inc
NYSE:EL
38.9B USD 2.7 -41.8 21.2 34.9
DE
Beiersdorf AG
XETRA:BEI
20.7B EUR 2.1 23.4 11.5 14.7
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.8 11.3 17.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 8.2 66.6 41.4 45.4
IN
Dabur India Ltd
NSE:DABUR
875.4B INR 6.8 48.4 36.3 44.9
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
NZ
Promisia Healthcare Ltd
NZX:PHL
Average P/E: 35.1
25.2
N/A N/A
FR
L'Oreal SA
PAR:OR
32.3
8%
4
UK
Unilever PLC
LSE:ULVR
23.8
13%
1.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
49.2
8%
6.1
UK
HALEON PLC
LSE:HLN
23.3
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -41.8 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.4
8%
2.9
JP
Kao Corp
TSE:4452
23.8
12%
2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
66.6
19%
3.5
IN
Dabur India Ltd
NSE:DABUR
48.4
12%
4
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NZ
Promisia Healthcare Ltd
NZX:PHL
Average EV/EBITDA: 41.7
24.5
N/A N/A
FR
L'Oreal SA
PAR:OR
18.7
5%
3.7
UK
Unilever PLC
LSE:ULVR
202.2
2%
101.1
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
35.7
8%
4.5
UK
HALEON PLC
LSE:HLN
14
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
21.2
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.5
-1%
N/A
JP
Kao Corp
TSE:4452
11.3
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
41.4
13%
3.2
IN
Dabur India Ltd
NSE:DABUR
36.3
11%
3.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NZ
Promisia Healthcare Ltd
NZX:PHL
Average EV/EBIT: 49.5
24.5
N/A N/A
FR
L'Oreal SA
PAR:OR
22.8
6%
3.8
UK
Unilever PLC
LSE:ULVR
234.9
2%
117.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.5
9%
4.4
UK
HALEON PLC
LSE:HLN
15.9
4%
4
US
Estee Lauder Companies Inc
NYSE:EL
34.9
25%
1.4
DE
Beiersdorf AG
XETRA:BEI
14.7
-1%
N/A
JP
Kao Corp
TSE:4452
17.4
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
45.4
13%
3.5
IN
Dabur India Ltd
NSE:DABUR
44.9
11%
4.1
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
PHL intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHL stock valuation using valuation multiples.
Wall Street Estimates
PHL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.